Axsome Therapeutics (AXSM) Cost of Revenue (2022 - 2026)
Axsome Therapeutics (AXSM) recorded Cost of Revenue of $13.56 million in Q2 2026, up 0.9% from $13.45 million a year earlier but down 7.9% from the prior quarter.
Axsome Therapeutics (AXSM) Cost of Revenue (2022 - 2026) Analysis & Trends
On a TTM basis, Axsome Therapeutics' Cost of Revenue came in at $52.53 million as of Jun 30, 2026, up 24.5% year-over-year; for FY2025, it came in at $47.48 million, up 42.6% from FY2024.
- Annual Cost of Revenue has increased for three straight years, with a three-year compound annual growth rate of 109.0% (FY2022 to FY2025).
- Across earlier years, Cost of Revenue came in at $33.3 million in FY2024 (+27.8%), $26.07 million in FY2023 (+401.4%) and $5.2 million in FY2022.
- Quarterly Cost of Revenue has ranged from $983,000 in Q2 2022 to $14.73 million in Q1 2026 over the past five years.
- On a year-over-year basis, Cost of Revenue has increased for nine consecutive quarters, with growth averaging 38.0% over the last eight quarters.
- Peak year-over-year performance for Cost of Revenue in the last five years was growth of 367.9% in Q2 2023, against a decline of 16.7% in Q1 2024 at the low end.
- Per Business Quant, the preceding three quarters came in at $14.73 million (Q1 2026), $12.33 million (Q4 2025) and $11.91 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cost of Rev (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | 3.27 Bn |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 8.05 Bn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | 4.29 Bn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | 4.40 Bn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | 3.71 Bn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | 2.52 Bn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | 2.81 Bn |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | 1.58 Bn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | 4.09 Bn |
| 10 | Axsome Therapeutics | 9.37 Bn | 8.10 Bn | 204.81 Mn | 13.56 Mn |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 13.56 Mn |
| Mar 31, 2026 | 14.73 Mn |
| Dec 31, 2025 | 12.33 Mn |
| Sep 30, 2025 | 11.91 Mn |
| Jun 30, 2025 | 13.45 Mn |
| Mar 31, 2025 | 9.79 Mn |
| Dec 31, 2024 | 10.51 Mn |
| Sep 30, 2024 | 8.44 Mn |
| Jun 30, 2024 | 8.06 Mn |
| Mar 31, 2024 | 6.30 Mn |
| Dec 31, 2023 | 7.38 Mn |
| Sep 30, 2023 | 6.53 Mn |
| Jun 30, 2023 | 4.60 Mn |
| Mar 31, 2023 | 7.56 Mn |
| Dec 31, 2022 | 2.29 Mn |
| Sep 30, 2022 | 1.92 Mn |
| Jun 30, 2022 | 983,000.00 |
Axsome Therapeutics Cost of Revenue API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cost-of-revenue&ticker=AXSM&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cost-of-revenue", "ticker": "AXSM", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=cost-of-revenue&ticker=AXSM&period=max&api_key=YOUR_API_KEY");
const data = await res.json();